KDR-H
|
HCC
|
KDR-H
|
HCC
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
KDR-H
|
Skin Cancer
|
KDR-H
|
Skin Cancer
|
pazopanib Sensitive: C3 – Early Trials
|
pazopanib Sensitive: C3 – Early Trials
|